Zhongjun Ma
Impact in
-
- Phytochemicals and Medicinal Plants
- Biotechnology top 2%
- Marine Sponges and Natural Products
Papers in
- Toxicology 10
- Bioactive Compounds and Antitumor Agents 10
- Pharmacology 43
- Microbial Natural Products and Biosynthesis 35
- Co-authors
- Wanjing DingNing LiXiaoyu ZhangJiaqi LiLiyan YuLiping LuoHaibin QuZhe Chen
- Journals
- Journal of Asian Natural Products Research (9 papers)Fitoterapia (7 papers)Journal of Medicinal Chemistry (6 papers)Phytochemistry Letters (5 papers)Journal of Natural Products (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Zhongjun Ma
130 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 111
- Complementary and alternative medicine 362
- Biotechnology 298
- Pharmacology 563
- Toxicology 107
- Pharmacology 195
Countries citing papers authored by Zhongjun Ma
This map shows the geographic impact of Zhongjun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongjun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongjun Ma more than expected).
Fields of papers citing papers by Zhongjun Ma
This network shows the impact of papers produced by Zhongjun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongjun Ma. The network helps show where Zhongjun Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongjun Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 9 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 8 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2021 | 36 | |
| 15 | 2021 | 14 | |
| 16 | 2019 | 48 | |
| 17 | 2015 | 4 | |
| 18 | 2014 | 18 | |
| 19 | 2008 | 15 | |
| 20 | 2006 | 4 |
About Zhongjun Ma
Zhongjun Ma is a scholar working on Toxicology, Pharmacology, Biochemistry, Biotechnology and Complementary and alternative medicine, having authored 136 papers that have together received 2.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (35 papers), Natural product bioactivities and synthesis (28 papers), Genomics, phytochemicals, and oxidative stress (14 papers), Marine Sponges and Natural Products (12 papers), Phytochemicals and Antioxidant Activities (12 papers), Phytochemistry and Biological Activities (12 papers), Bioactive Compounds and Antitumor Agents (10 papers) and Phytochemicals and Medicinal Plants (9 papers). The work is most often cited by research in Complementary and alternative medicine (362 citations), Biotechnology (298 citations), Pharmacology (563 citations), Toxicology (107 citations) and Pharmacology (195 citations). Zhongjun Ma has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Wanjing Ding, Ning Li, Xiaoyu Zhang, Jiaqi Li, Liyan Yu, Liping Luo, Haibin Qu, Zhe Chen, Yong‐Jun Jiang and Xiaoqiong Ma. Their work appears in journals such as Journal of Asian Natural Products Research, Fitoterapia, Journal of Medicinal Chemistry, Phytochemistry Letters and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.